Roberta Buono

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Multiple Myeloma

Chronic Lymphocytic Leukemia

Top Venues

Cancer research

Cancer research communications

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Franca Raucci, Claudio Vernieri, Maira Di Tano, Francesca Ligorio, Olga Blaževitš, Samuel Lazzeri, Anastasiya Shmahala, Giuseppe Fragale, Giulia Salvadori, Gabriele Varano, Stefano Casola, Roberta Buono, Euplio Visco, Filippo G De Braud, Valter Daniel Longo
Cyclic fasting-mimicking diet plus bortezomib and rituximab is an effective treatment for chronic lymphocytic leukemia. Cancer research (2024)
Franca Raucci, Claudio Vernieri, Maira Di Tano, Francesca Ligorio, Olga Blaževitš, Samuel Lazzeri, Anastasiya Shmahala, Giuseppe Fragale, Giulia Salvadori, Gabriele Varano, Stefano Casola, Roberta Buono, Euplio Visco, Filippo G De Braud, Valter Daniel Longo
Cyclic Fasting-Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia. Cancer research 84 (7) (2024)
Dennis Juarez, Roberta Buono, Shannon M Matulis, Vilas A Gupta, Madeleine R Duong, Jacob Yudiono, Madhuri Paul, Sharmila Mallya, Grace Diep, Peter Hsin, Alexander Lu, Sang Mi Suh, Vy M Dong, Andrew W Roberts, Joel D Leverson, Muhammad Jalaluddin, Zhuangzhuang Liu, Orlando F Bueno, Lawrence H Boise, David A Fruman
Statin-induced mitochondrial priming sensitizes multiple myeloma cells to BCL2 and MCL1 inhibitors. Cancer research communications (2023)
Maira Di Tano, Franca Raucci, Claudio Vernieri, Irene Caffa, Roberta Buono, Maura Fanti, Sebastian Brandhorst, Curigliano Giuseppe, Alessio Nencioni, Filippo de Braud, Valter Daniel Longo
Synergistic effect of fasting-mimicking diet and vitamin C against KRAS mutated cancers. Nature communications 11 (1) (2020)